8696879946_c47d0f98fa_o.jpg
cells14.jpg
cells1.jpg
8696879946_c47d0f98fa_o.jpg

NEW! Our biotech finance handbook is now available!


SCROLL DOWN

NEW! Our biotech finance handbook is now available!


 

Now available on amazon!

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is the one-stop reference you need, whether you’re making investment decisions, pitching to potential partners, or estimating the value of an R&D program.

  • Vetted benchmarks for key drivers of income, expenses, and valuation.
  • Proprietary analyses from Pharmagellan’s experienced consulting team.
  • More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

"Deserves a spot on the bookshelf of every biotech CFO."

- Bruce Booth, Partner, Atlas Venture

 

Free sample chapter: Projecting Market Share for R&D-Stage Biotechs

Read the table of contents and get more details here

 

buy it on amazon

cells14.jpg

Discover how far you can go.


SCROLL DOWN

Discover how far you can go.


 

Pharmagellan unlocks the true value in your biotech development pipeline.


Biotech companies typically develop deep research portfolios, but many promising early-stage projects don't progress if the team is stretched thin and focused on the lead asset.

To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.

Pharmagellan offers just that: expert advice and project execution to biotech companies willing to discover how far they can go.

 


Research
& Development

Preclinical, translational, and early clinical strategy and execution

 

commercial
& Corporate

Competitive and financial analysis of products, portfolios, and companies

 
cells1.jpg

Navigations


Highlights from the blog

SCROLL DOWN

Navigations


Highlights from the blog